SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Shares of Sarepta Therapeutics (NASDAQ: SRPT) head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its experimental RNA therapy SRP‑1003 and weigh it against fresh FDA warnings and trial setbacks tied to its gene therapy Elevidys. SRPT stock today at a glance As of Monday’s close (November 24, 2025), here’s where SRPT stands: In other words, Monday’s bounce was meaningful, but comes after a brutal collapse from triple‑digit levels earlier in 2025. New SRP‑1003 data: a rare bright spot for SRPT stock On Monday, Sarepta released a progress update for
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. (NASDAQ: RUM) heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto giant Tether and a transformational AI infrastructure deal with Germany’s Northern Data. As of Monday, November 24, RUM closed at $6.51, up about 14.4% on the day, after trading between $5.92 and $6.57 on unusually heavy volume of roughly 7.2 million shares, well above recent averages. FinancialContent That follows a 7% gain on Friday, lifting the stock more than 22% over the last two sessions and putting it back near the upper end of
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital, Inc. (NASDAQ: NUAI) heads into Tuesday’s session on the back of a sharp rally and a major expansion update for its flagship Texas AI data center project. As of Monday’s close on November 24, NUAI finished at $4.40, up about 15.8% on the day, with roughly 8.6 million shares traded on the Nasdaq. StockAnalysis The stock remains deeply volatile and, despite the latest bounce, is still down more than 60% over the past 12 months. StockAnalysis This move followed fresh news that the company’s joint venture has locked in more land for its Texas AI
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s Corporation (NYSE: KSS) heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday shopping season ramping up—all against a backdrop of heavy short interest and lingering doubts about the department‑store model. As of early Tuesday, KSS is trading around $15.70 per share, giving Kohl’s a market value of roughly $1.8 billion and leaving the stock in the lower half of its 52‑week range of about $6.04 to $21.39. GuruFocus+1 Key Takeaways for KSS Stock on November 25, 2025 KSS Stock Price Today: Volatile but Off the Lows
25 November 2025
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still roughly 24% below their early‑November high near $168. StockAnalysis+1 Over the past month, the stock has dropped almost 20%, even after Monday’s rebound, while it remains up around 10% year‑to‑date and down about 12% over the last 12 months. MarketBeat+1 That combination of strong year‑to‑date gains, a sharp recent sell‑off, and a big AI narrative makes Dell one of the
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high
25 November 2025
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and above its original target. Viking Therapeutics InvestorRoom As of yesterday’s close (Monday, November 24), VKTX changed hands at $34.65, implying a market capitalization of roughly $3.9 billion. Stock Titan Shares sit well below their 52‑week high of $56.25, but far above the 52‑week low of $18.92, underscoring how volatile the weight‑loss drug trade has become. Investing.com+1 With Phase 3 trials
Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet

Date: November 25, 2025 Johnson & Johnson (NYSE: JNJ) heads into Tuesday’s session at or near record highs, riding a wave of bullish options activity, a key ex‑dividend date today and a string of growth-focused pipeline moves in cancer and neuroscience. As of the latest completed trading session on Monday, November 24, JNJ was trading around $206 per share, close to its 12‑month high just under $207, with a 12‑month low near $141, a price/earnings ratio around 20 and a dividend yield in the ballpark of 2.5%–2.6%.MarketBeat+1 The stock is up more than 7% since the first trading day of
Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

Coca-Cola (KO) Stock on November 25, 2025: Price, Dividend and Outlook After Q3 Earnings

As markets head into the Tuesday, November 25, 2025 session, Coca-Cola Company (The) stock (NYSE: KO) is trading in classic “steady blue‑chip” fashion: modest price moves, strong dividend support, and quietly improving fundamentals. As of the close on Monday, November 24, KO finished at $72.59, down about 0.5% on the day but still up roughly 13–14% over the last 12 months and trading well above both its 50‑day and 200‑day moving averages.StockAnalysis Over the past year, the stock has moved in a range of roughly $60–$74, leaving it nearer the upper half of that band as investors position for year‑end.MarketBeat+1
25 November 2025
DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest in compliance-focused AI.Simply Wall St+1 Now, heading into Tuesday, November 25, 2025, DGNX is back in the spotlight after the company signed a non‑binding memorandum of understanding (MOU) to acquire The Remedy Project, a specialist in human-rights risk and worker-centered remediation for global supply chains.ir.diginex.com+2Nasdaq+2 Below is a detailed look at where DGNX stock stands today, what’s driving the latest
25 November 2025
Palo Alto Networks (PANW) Stock Today – November 25, 2025: Earnings ‘Beat and Raise’, AI Deals and What to Watch Next

Palo Alto Networks (PANW) Stock Today – November 25, 2025: Earnings ‘Beat and Raise’, AI Deals and What to Watch Next

Palo Alto Networks, Inc. (NASDAQ: PANW) heads into the November 25, 2025 trading day as one of the most closely watched cybersecurity stocks on Wall Street, with fresh headlines about its earnings, big AI‑focused acquisitions and a sharp pullback in the share price all competing for investor attention. As of the last completed U.S. trading session on Monday, November 24, 2025, Palo Alto Networks stock closed at $183.89, up about 0.5% on the day, after trading between roughly $182 and $187 on volume of just over 11 million shares.StockAnalysis That closing level leaves PANW well below its late‑October high near
Lam Research (LRCX) Stock Jumps Over 5% as AI Chip Rally Lifts Semiconductors – Price, News and Outlook for 25 November 2025

Lam Research (LRCX) Stock Jumps Over 5% as AI Chip Rally Lifts Semiconductors – Price, News and Outlook for 25 November 2025

Lam Research Corporation (NASDAQ: LRCX) is back in the spotlight after a powerful tech-led rally pushed the stock more than 5% higher in the latest U.S. trading session, adding to an already stellar 2025 run. As of the morning of 25 November 2025, the freshest data investors can see reflects Monday’s close at about $150.38 per share, up roughly 5.4% on the day. barchart.com While Lam hasn’t issued any new company press releases today, several fresh market reports and analyst pieces from the last few days — plus Monday’s sharp move — are shaping the story for LRCX right now.
25 November 2025

Stock Market Today

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
New York, Feb 7, 2026, 07:02 (EST) — Market closed. Cadence Bank shares (CADE) last traded at $42.11 on Jan. 30 and have been marked inactive, leaving investors with little to watch on the ticker itself heading into Monday’s U.S. session. (StockAnalysis) What matters now is the paperwork, not the tape. Under the terms of Huntington Bancshares’ takeover, each Cadence common share was converted into the right to receive 2.475 Huntington common shares — the exchange ratio — with cash paid in lieu of any fractional share. (SEC) That shifts the price action to Huntington. Huntington shares closed on Friday
NIO stock jumps on profit alert, with Monday’s open in focus

NIO stock jumps on profit alert, with Monday’s open in focus

7 February 2026
NIO shares jumped 7.23% to $5.04 Friday after the company forecast a swing to adjusted operating profit of up to 1.2 billion yuan for the fourth quarter. Trading volume reached 90.8 million shares, far above average. Nio’s deliveries rose 72% to 124,807 vehicles in the quarter. The company said results are preliminary and unaudited, with final figures due in March.
Snap stock price bounces to $5.22 after upgrades — what traders watch next week

Snap stock price bounces to $5.22 after upgrades — what traders watch next week

7 February 2026
Snap Inc. shares closed up 2% at $5.22 Friday after a volatile week, with 94 million shares traded. The company forecast Q1 revenue below analyst expectations, despite a fourth-quarter beat and a 28% rise in active advertisers. Daily active users fell by 3 million to 474 million. Analysts remain divided, with some upgrading and others trimming price targets.
Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

Bradesco stock drops on 2026 guidance — what BBDC4 investors watch next week

7 February 2026
Bradesco’s preferred shares fell 2.55% to 20.61 reais Friday after the bank issued 2026 guidance pointing to slower growth in some areas. Fourth-quarter recurring net income rose 20.6% to 6.5 billion reais, with 2025 ROAE at 15.2%. The Ibovespa closed up 0.45%. Bradesco ADRs ended down 0.5% at $3.98 in New York.
Go toTop